HER2-low breast cancer refers to cancers with HER2 IHC staining results of 1+ or 2+ and negative ISH, results, and this kind of cancers accounts for 45% to 55% of breast cancer cases (10). This evidence concerns the gene ERBB2 and breast carcinoma.